Primary care management of hidradenitis suppurativa: a cross-sectional survey of UK GPs.

Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that causes painful discharging nodules and skin tunnels. HS has associations with several systemic diseases, including cardiovascular disease (CVD), anxiety, and depression. High levels of chronic morbidity suggest an important role for primary care. However, little evidence exists regarding current management of HS and its comorbidities in UK general practice. To describe current practice among UK GPs in treating and referring people with HS. A web-based survey was circulated to UK Primary Care Dermatology Society (PCDS) members and GPs in Forth Valley, Scotland. Survey responses were analysed with descriptive statistics. A total of 134 UK GPs completed the survey. Seventy per cent (<i>n</i> = 94) saw at least one patient with HS in the previous month. Ninety-four per cent (<i>n</i> = 125/133) reported confidence in diagnosis, and 89% (<i>n</i> = 120/134) in initial treatment of HS. Most GPs initiated topical treatments and extended courses of oral antibiotic for HS, and many gave advice on adverse lifestyle factors. A minority provided analgesia, or screening for CVD risk factors, and depression. Most GPs referred to dermatology if secondary care input was required, with few referrals to specialised multidisciplinary services. GPs regularly diagnose and manage uncomplicated HS, but screening for important comorbidities associated with HS is not common practice.